Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enteral Glutamine in ICU Patients
NCT02998931Phase 3Completed
- Sponsor
- Shahid Beheshti University
- Start
- Nov 2016
- Primary completion
- Aug 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of glutamine in critical illness (2 arms), sponsored by Shahid Beheshti University. Primary endpoint: Occurrence of infection at Day 28. Started Nov 2016; status: completed.
02
Drugs
glutamine
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT02998931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02998931.